[Frontiers in Bioscience 2, d253-259, June 1, 1997]
Reprints
PubMed
CAVEAT LECTOR



Table of Conents
 Previous Section   Next Section

GENES IMPLICATED IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE

Hriday K. Das, Ph.D., and Harbans Lal, Ph.D.

Department of PharmacologyUniversity of North Texas Health Science Center at Fort Worth, Fort Worth, Texas 76107

Received 4/4/97; Accepted 5/28/97

4. REFERENCES

1. H. K. Das & H. Lal. Pathogenesis of Alzheimer's Disease: Current status on apolipoprotein E4 gene research. Rev. Neurosciences 7, 277-283 (1996)

2. R. Katzman. Medical progress, Alzheimer's disease. N Eng J Med 314, 964-967 (1986)

3. G. D. Schellenberg, T. D. Bird, E. M. Wijsman, H. T. Orr, L. Anderson, E. Nemens, J. A. White, L. Bonnycastle, J. L. Weber, M. E. Alonso, H. Potter, L. L. Heston & G. M. martin. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-670 (1992)

4. R. Sherrington, E. I. Rogaev, Y. Liang, E. A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman, T. Tsuda, L. Mar, J. -F. Foncin, A. C. Bruni, M. P. Montesi, S. Sorbi, I. Rainero, L. Pinessi, L. Nee, I. Chumakov, D. Pollen, A. Brookes, P. Sanseau, R. J. Polinsky, W. Wasco, H. A. R. Da Silva, J. L. Haines, M. A. Pericak-Vance, R. E. Tanzi, A. D. Roses, P. E. Fraser, J. M. Rommens & P. H. St George-Hyslop. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760 (1995)

5. P. St. George-Hyslop, J. Haines, E. Rogaev, M. Mortilla, G. Vaula, M. Pericak-Vance, J. F. Foncin, M. Montesi, A. Bruni, S. Sorbi, I. Rainero, L. Pinessi, D. Pollen, R. Polinsky, L. Nee, J. Kennedy, F. Macciardi, E. Rogaeva, Y, Liang, N. Alexandrova, W. Lukiw, K. Schlumpf, R. Tanjzi, T. Tsuda, L. Farrer, J. M. Cantu, R. Duara, I. Amaducci, L. Bergamini, J. Gusella, A. Roses & D. Crapper McLachlan. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genetics 2, 330-334 (1992)

6. C. Van Broeckhoven, H. Backhovens, M. Cruts, G. De Winter, M. Bruyland, P. Cras & J. J. Martinl. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nature Genetics 2, 335-339 (1992)

7. A. Goate, M. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, M. Pericak-Vance, A. Roses, R. Williamson, M. Rossor, M. Owen & J. Hardy. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991)

8. H. Karlinsky, G. Vaula, J. L. Haines, J. Ridgley, C. Bergeron, M. Mortilla, R. G. Tupler, M. E. Percy, Y. Robitaille, N. E. Nolde, T. C. K. Yip, R. E. Tanzi, J. F. Gusella, R. Becker, J. M. Berg, D. R. Crapper McLachlan & P. H. St. George-Hyslop. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and missense mutation in the codon 717 of the b-amyloid precursor protein gene. Neurology 42, 1445-1453 (1992)

9. W. J. Strittmatter, A. M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. S. Salvesen & A. D. Roses. Apolipoprotein E: High-avidity binding to beta amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5), 1977-1981 (1993)

10. E. Levy-Lahad, E. M. Wysman, E. Nemens, L, Anderson, K. A. B. Goddard, J. L. Weber, T. D. Bird & G. D. Schellenberg. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977 (1995)

11. E. I. Rogaev, R. Sherrington, E. A. Rogaeva, G. Levesque, M. Ikeda, Y. Liang, H. Chi, C. Lin, K. Holman, T. Tsuda, L. Mar, S. Sorbl, B. Nacmias, S. Placentini, L. Amaducci, I, Chumakov, D. Cohen, L. Lannfelt, P. E. Fraser, J. M. Rommens & P. H. St. George-Hyslop. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778 (1995)

12. K. Duff, C. Eckman, C. Zehr, X. Yu, C-M. Prada, J. Perez-tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M. N. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy & S. Younkin. Increased amyloid-42 (43) in brains of mice expressing mutant presenilin 1. Nature, 383, 710-712 (1996)

13. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T. D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Seilkoe & S. Younkin. Secreted amyloid -protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996)

14. B. Wolozin, K. Iwasaki, P. Vito, J. K. Ganjei, E. Lacana, T. Sunderland, B. Zhao, J. W. Kusiak, W. Wasco & L. D'Adamino. Participation of Presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer's mutation. Science 274, 1710-1713 (1996)

E. H. Corder, A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses & J. L. Hainse. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993)

15. J. F. Diedrich, H. Minnigan, R. I. Carp, J. N. Whitaker, R. Race, W. Frey & A. T. Haase. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65, 4759-4768 (1991)

16. Y. Namba, M. Tomonaga, H. Kawasaki, E. Otomo & K, Ikeda. Apolipoprotein E immuno-reactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and Kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541, 163-166 (1991)

17. SB Prusiner, KK Hsiao, DE Bredesen & SJ DeArmond. In: Handbook of Clinical Neurology , Ed. RR McKendall. (Elsevier, Amsterdam). 12, 543-580 (1989)

18. W. J. Strittmatter, K. H. Weisgraber, D. Y. Huang, D. Li-Ming, G. S. Salvesen, M. Pericak-Vance, D. Schmechel, A. M. Saunders, D. Goldgaber & A. D. Roses. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90, 8098-8102 (1993)

19. D. Levitan, T. G. Doyle, D. Brousseau, M. K. Lee, G. Thinkaran, H. H. Slunt, S. S. Sisodia & I. Greenwald. Assessment of normal and mutant presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 93, 14840-14944 (1996)

20. P. Vito, E. Lacana & L. D' Adamino. Interfering with apoptosis: Ca+2- binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525 (1996)

21. R. E. Tanzi, G. Vaula, D. M. Romano, M. Mortilla, T. L. Huang, R. G. Tupler, W. Wasco, B. T. Hyman, J. L. Haines, B. J. Jenkins, M. Kalaitsidaki, A. C. Warren, M. C. McInnis, S. E. Antonarakis, H. Karlinsky, M. E. Percy, L. Connor, J. Growdon, D. R. Crapper-Mclachlan, J. F. Gusella & P. H. St George-Hyslop. Assessment of amyloid -protein precursor gene mutations in a large set of familial and sporadic Alzheimer's disease cases. Am J Hum Genet 51, 273-282 (1992)

22. S. S. Sisodia, E. H. Koo, K. Beyreuther, A. Unterbeck & D. L. Price. Evidence that betab-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495 (1990)

23. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang & G. Cole. Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996)

24.R. Etcheberrigaray, E. Ito, C. S. Kim & D. L. Alkon. Soluble betab-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. Science 264, 276-279 (1994)

25. R. Etcheberrigary, E. Ito, K. Oka, B. Tofel-Grehl & G. E. Gibson. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer's disease. Proc Natl Acad Sci USA 90, 8209-8213 (1994)

26. A. I. Bush, W. H. Pettingell, G. Multhaup, M. Paradis, J-P. Vonsattel, J. F. Gusella,Beyreuther, C. L. Masters & 27. R. E. Tanzi. Rapid induction of Alzheimer A amyloid formation by zinc. Science 265, 1464-1467 (1994) 28. S. S. Ball & V. H. Mah. Apolipoprotein E4, mental vitality in youth and Alzheimer's disease in old age? Age 16, 136-149 (1993)

29. P. R. Wenham, W. H. Price & G. Blundell. Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159 (1991)

30. M. Lilly-Stauderman, T. L. Brown, A. Balasubramaniam & J. A. Harmony. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells. J Lipid Res 34(2): 190-200 (1993)

31. R. A. Torkeltaub, C. A. Dyer, J. Martin & L. K. Curtiss. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apoE and demonstration of apoE binding to urate crystals in vivo. J Clin Invest 87(1), 20-26.22 (1991)

32. T. Wisniewski, A. Golabek, E. Matsubara, J. Ghiso & B. Frangione. Apolipoprotein E: binding to soluble Alzheimer's betab-amyloid. Biochem Biophys Res Commu 192(2), 359-365 (1993)

33. B. P. Nathan, S. Bellosta, D. A. Sanan, K. H. Weisgraber, R. W. Mahley & R. E. Pitas Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 264, 850-852 (1994) 34. D. E. Schmechel, A. M. Saunders, W. J. Strittmatter, B. J. Crain, C. M. Hulette, S. H. Joo, M. A. Pericak-Vance, D. Goldbarger & A. D. Roses. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acd Sci USA 90, 9649-9653 (1993)

35. H. Shimano, N. Yamada, M. Katsuki, M. Shimada, T. Gotoda, K. Harada, T. Murase, C. Fukazawa, F. Takaku & Y. Yazaki. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc Natl Acad Sci USA 89 (5), 1750-1754 (1992)

36. A. S. Pulp, J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin & J. L. Breslow. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 (2), 343-353 (1992)

37. S. H. Zhang, R. L. Reddick, J. A. Piedrahita & N. Maeda. Spontaneous hypercholesteroemia and arterial lesions in mice lacking apolipoprotein E. Science 258 (5081), 468-471 (1992)

38. H. K. Das, J. McPherson, G. A. Bruns, S. K. Karathanasis & J. L. Breslow. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 260, 6240-6247 (1985)

39. G. W. Rebeck, J. S. Reiter, D. K. Strickland & B. T. Hyman. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11, 575-580 (1993)

40. W. Roush. Protein studies try to puzzle out Alzheimer's Tangles. Science 267, 793-794 (1995) 41. S. L. Peleeh. Networking with proline-directed protein kinases implicated in tau phosphorylation. Neurobiol Aging 16 (3), 247-256 (1995)